Abstract
Severe focal vasoconstriction during administration of intravenous ergonovine (Erg) is indicative of coronary vasospasm. We hypothesized that outcomes of patients with intermediate response to Erg are similar to those with severe vasoconstriction. From 2005-2010, 1,178 consecutive patients
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
